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A B S T R A C T
Some neurodegenerative diseases at early stage may not drastically affect basic gait ability, whereas
more demanding locomotor tasks are more prone to disease-induced abnormalities. In this study, we
evaluated the interday test–retest reliability, 4–6 weeks apart, of instrumented movement analysis on a
group of 20 subjects with Charcot–Marie–Tooth (CMT) disease considering a set of kinematic and kinetic
curves and related parameters obtained during natural walking (NW) and faster walking, heel and toe-
walking, step ascending and descending.
Results showed that the reliabilitywas good for NW,with the exception of trunk curves, pelvic tilt and
EMG proﬁles (moderate reliability), and trunk ROM in sagittal/transverse plane (poor reliability).
Comparing our results with literature, CMT patients did not present a greater variability during NW than
healthy subjects or patients with diseases of CNS. Additional locomotor tasks showed a slight reduction
of reliability, although themoderate-to-good level shown inNWwas almost never reduced to poor.Most
of SEM values (absolute measurement errors) were smaller than 58, a clinically acceptable threshold. In
particular THS, an ankle joint related parameter computed across heel and toe-walking tasks, showed an
optimal reliability (ICC = 0.95, SEM = 2.78) and correlation with CMT clinical scores. Toe and heel-
walking and step ascending tasks maximised the number of parameters with a moderate-to-good
correlation with patients’ clinical status. We concluded that, in addition to natural walking, more
challenging locomotor tasks are good candidates to provide reliable and sensitive outcomemeasures for
CMT patients.
 2011 Elsevier B.V.
Contents lists available at ScienceDirect
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Charcot–Marie–Tooth disease (CMT) is the most frequent
inherited neuromuscular disorder (prevalence 17–40/100000)
[1] and presents different genetic forms with similar clinical
symptoms, i.e. distal limb muscle wasting and weakness, skeletal
deformities, distal sensory loss and reduced deep tendon reﬂexes
[2]. The underlying pathogenic mechanism let the identiﬁcation of
a primary demyelinating variety (CMT1, CMT4) and a primary
axonopathy (CMT2), although intermediate forms are recognised
(CMTX1). The most predominant genetic forms are CMT1A (40–
50%), associated with a chromosome duplication involving the* Corresponding author at: Polo Tecnologico, IRCCS S. Maria Nascente,
Fondazione Don Carlo Gnocchi Onlus, Via Capecelatro 66, 20148 Milano, Italy.
Tel.: +39 02 40308305; fax: +39 02 4048919.
E-mail address: mferrarin@dongnocchi.it (M. Ferrarin).
0966-6362  2011 Elsevier B.V.
doi:10.1016/j.gaitpost.2011.03.007
Open access under CC BY-NC-ND license.Peripheral Myelin Protein-22 gene, and CMTX1 (10%). Symptoms
often start in childhood and the disease then follows a slowly
progressive disabling course, although there is a large variability in
severity, whichmay occur also within the same CMT type and even
the same family. This aspect highlights the crucial role of
functional assessment for a correct individual planning of CMT
patients’ clinical management.
There is still no pharmacological treatment for CMT and clinical
approaches rely on physiotherapy, orthotics and surgical treatment
of skeletal deformities. Ascorbic acid has been shown effective in an
animalmodel of CMT1A and randomized controlled trials have been
performed in humans, but thus far the results have been dismaying
[3–5]. One major problem in conducting clinical trials is the slow
disease course, making a major challenge the identiﬁcation of
sensitive-to-change outcome measures. Beside clinical and neuro-
physiological assessments, a quantitative evaluation of locomotor
functionswouldprovide importantoutcomemeasureswithahigher
sensitivity to progression-related or therapy-induced changes.
M. Ferrarin et al. / Gait & Posture 34 (2011) 36–43 37The progression of motor and sensory dysfunction usually
follows a disto-proximal gradient, starting from the intrinsic foot
muscles and then spreading to the leg muscles, thus affecting
locomotor functions. The gait pattern is characterised by foot-drop
(a reduced capacity to lift the forefoot during the swing phase of
walking due to dorsiﬂexormuscles weakness) and a compensatory
increase of hip and knee ﬂexion [6,7]. Moreover, patients who have
also a plantar ﬂexor deﬁcit,may present a clumsy gait pattern, with
reduced cadence and step-length, and a broader support area [7].
Instrumented gait analysis, which allows for a precise analysis
of human gait through optoelectronic systems, is a technique
increasingly adopted in several locomotor disorders (for example
cerebral palsy [8], adult hemiplegics [9] and focal dystonia [10]) for
the planning of therapeutic interventions and the outcome
assessment. Recently, some authors documented the abnormali-
ties of gait biomechanics of CMT [6] and found subgroups with
speciﬁc functional deﬁcits [7]. However, the reliability of GA in
CMT disease must be assessed, as already done in other diseases
[11–13].
As at an early stage CMTmay not drastically affect the basic gait
ability, a multitask protocol including more demanding locomotor
functions, like toe- and heel-walking, step ascending and
descending, should be considered to increase sensitivity [14], as
shown for patients with facioscapulohumeral dystrophy [15].
Accordingly, the aim of the present study was to assess the inter-
session reliability of a multitask locomotion protocol of movement
analysis applied on a group of CMT patients.
2. Methods
2.1. Subjects
Inclusion criteria were a diagnosis of CMT based on clinical,
electrodiagnostic and genetic criteria. Exclusion criteria were
presence of other neurological diseases or unrelated clinical
conditions affecting locomotor functions; inability to walk
barefoot without assistance and/or orthoses; previous double or
triple arthrodesis at the ankle limiting joint ROM.
Twenty CMT subjects have been included, 13 males and 7
females, 14 with CMT1A, 4 with CMTX1 and 2 with CMT2. Mean
age was of 24.6 years (SD: 17.1; range: 8–68), mean height
160.7 cm (SD: 14.9; range: 138–187), mean weight 53.4 kg
(SD:13.9; range: 36–81) and mean Charcot–Marie–Tooth Neurop-
athy Examination Score (CMTES)1 of 6.3 (SD: 2.9; range: 2–11).
All subjects gave informed consent and the protocol was
approved by the local ethical committee.
2.2. Study design
A single evaluator, test–retest design on 2 days, 4–6 weeks
apart, was adopted to assess the reliability of output parameters.
2.3. Instrumentation and procedure
Kinematic data were collected with a 9-camera SMART-E
motion capture system (BTS, Milano, Italy) sampling at 60 Hz and
using the total-body LAMB marker set [16]. Two force plates
(Kistler, Winterthur, Switzerland) were used to measure ground
reaction forces (GRF) at 960 Hz sampling frequency. Surface
electromyography signals (EMG) were recorded with a 8-channel
and 1 kHz sampling frequencywireless ZeroWire electromyograph1 CMTNS is a composite scale speciﬁcally developed and validated for CMT
disease and includes 7 clinical items and 2 electrophysiological items [22]. CMT
Examination Score (CMTES) indicates the clinical part of the scale, with a score
ranging between 0 (normal) and 28 (worst).(Aurion, Milano, Italy), using 10 mmdiameter electrodes at 20 mm
inter-electrodic distance and 10–200 Hz bandpass ﬁltering. Tested
muscles included Tibialis Anterior, Soleus, Gastrocnemius Media-
lis, Peroneus Longus, Rectus Femoris, Vastus Medialis, Biceps
Femoris and Gluteus Maximus of the most affected side or, in case
of symmetry, of the right side.
The experimental protocol included 6 locomotor tasks:
walking at natural (NW) and fast speed (FW), toe-walking
(TW) and heel-walking (HW), step ascending (SA) and descend-
ing (SD). Each task was practiced and then repeated until ﬁve
successful trials were recorded. The subject was asked to walk
along a 12 m long walkway at self-selected speed (NW) and then
at fastest speed, without running (FW). TW and HW tasks were
performed at self-selected speed, asking the subject to maximise
the lift of heel and toe from ground during walking. SA task
consisted in climbing a two-step stair (step height: 18 cm, step
depth: 30 cm), starting from ground level and stopping on the
second step. The contrary was performed in SD task. Only the
ﬁrst step (a rigid wooden structure positioned on one force
plate) provided GRF data. All tasks were performed barefoot and
no instruction was given to the subjects about targeting the
platform.
2.4. Data analysis
Markers’ coordinates were low-pass ﬁltered (6 Hz cut-off
frequency). Individual anthropometric parameters were computed
from a static calibration trial, and used for estimation of internal
joint centers. These, in turn, enabled calculation of trunk [17],
pelvis and lower limb kinematics [16] during the locomotor tasks.
Inverse dynamics let to compute moments and powers at the
ankle, knee and hip joints. Dynamic data were computed in
absolute terms as suggested by Fortin et al. [13] for test–retest
reliability studies. Spatio-temporal gait parameters were normal-
ized to subject’s body height (BH). All kinematic and kinetic
variableswere time-normalized as a percentage of thewhole stride
duration (0–100%) and ensemble averages were then calculated.
EMG signals underwent rectiﬁcation, low-pass ﬁltering (Butter-
worth 5th order, 3 Hz cutoff frequency) and dynamic maximum
normalization (to themaximum value across all the trials of a task)
for each muscle independently.
Speciﬁc values (maximum, minimum, values at speciﬁc time
points within the gait cycle) were selected on each variable, in
order to evidence speciﬁc clinical signs (e.g. foot drop, plantar
ﬂexor failure, joint ROM and their changes during heel- and toe-
walking, compensatorymovements at hip and knee during swing).
Each parameter was averaged across the ﬁve trials. A detailed
nomenclature of these parameters is presented in Table 1 andmost
of them are shown in Fig. 1.
Intersession reliability was quantiﬁed by the coefﬁcient of
multiple correlation (CMC), the intraclass correlation coefﬁcient
(ICC) and the standard error of measurement (SEM).
The CMC is an index of consistency of waveforms between two
sessions and has a range between 0 (no consistency) and 1 (perfect
reliability). Kinematic curves were depurated of their mean value
before calculating CMCs as suggested by Kadaba et al. [18].
Correlation between CMCs and age was assessed by means of
Pearson’s Rho coefﬁcient.
Intersession reliability on selected parameters was assessed by
the ICC. Model 2,k (with k = 5 repetitions) was adopted between
the 6 possible versions [19], since the subjectswere assessed by the
same rater and the parameters were the average over the ﬁve
repetitions for each task. As suggested by Portney and Watkins
[20], CMC and ICC values above 0.75 indicated good reliability,
those between 0.5 and 0.75 moderate reliability and those under
0.5 poor reliability.
Table 1
Mean and standard deviation values of parameters for each locomotor task for the considered population (N=20 subjects with CMT). Codes for tasks: NW=natural speed
walking; FW=maximum speed walking; TW= toe-walking; HW=heel walking; SA= step ascending; SD= step descending.
Mean St Dev
Parameter Code Unit NW FW TW HW SA SD
Spatio-temporal
Gait speed normalized to body height SN [%BH/s] 70.411.7 100.518.4 55.417.6 36.614.0 29.23.5 28.83.7
Cadence Cadence [steps/min] 112.29.6 140.716.0 110.119.5 103.322.8 73.56.5 91.19.6
Stride length normalized to body height SLN [%] 74.97.0 86.28.9 59.413.9 42.813.4 29.02.3 33.56.1
Stance duration as percent of gait cycle Stance% [%] 61.32.8 60.24.3 64.75.3 68.56.1 68.23.0 70.04.0
First double support duration as % of
gait cycle
Double% [%] 11.13.3 9.42.8 15.56.5 18.66.5 17.63.4 16.15.5
Kinematics
Trunk ROM in sagittal plane (ﬂexion TSROM [8] 4.62.3 6.25.2 5.92.5 7.12.6 14.86.3 11.54.4
Trunk ROM in frontal plane (bending TFROM [8] 5.62.4 6.03.1 7.02.9 8.53.1 14.86.1 14.67.5
Trunk ROM in transverse plane (rotation TTROM [8 8.34.0 8.56.1 12.88.9 13.18.1 14.15.4 17.67.0
Hip angle at foot strike HSFS [8] 31.68.5 36.59.6 30.77.6 28.310.0 51.172.3 20.69.2
Hip angle at foot off HSFO [8] 0.910.9 2.112.0 4.411.9 16.613.3 11.710.7 32.714.4
Hip extension peak HSPK [8] 32.38.7 37.19.4 31.17.6 29.710.7 68.99.3 33.613.7
Hip ﬂex/extension ROM HSROM [8] 48.25.4 55.16.4 41.16.1 31.58.3 76.664.8 39.07.9
Hip ab/adduction ROM HFROM [8] 12.23.0 14.74.7 11.14.4 13.14.1 20.17.3 19.96.2
Knee angle at foot strike KSFS [8] 12.36.4 17.16.9 18.38.5 5.85.3 66.08.7 14.44.5
Knee angle at foot off KSFO [8] 42.15.8 43.78.5 37.910.0 37.014.1 18.96.5 93.95.5
Knee ﬂex/extension ROM KSROM [8] 62.06.0 67.46.1 49.28.6 45.318.5 66.29.8 88.68.8
Knee ﬂexion peak in stance KSPK1 [8] 42.15.8 43.88.5 38.39.9 37.113.9 70.17.6 93.95.6
Knee ﬂexion peak in swing KSPK2 [8] 68.46.7 71.27.5 58.410.0 46.818.1 77.88.1 101.97.8
Ankle angle at foot strike ASFS [8] 29.27.0 29.18.1 42.18.6 27.28.6 25.09.7 43.47.6
Ankle angle at foot off ASFO [8] 33.28.2 35.87.2 48.110.1 26.210.1 42.88.3 35.011.5
Ankle dorsi/plantaﬂexion ROM ASROM [8] 30.49.4 31.512.3 28.88.1 21.410.8 42.67.9 47.78.4
Ankle dorsi/plataﬂexion ROM in swing ASROMsw [8] 15.24.5 15.76.7 16.76.1 8.85.2 24.06.5 16.07.8
Foot angle at foot strike FoSFS [8] 11.98.2 13.18.7 34.77.8 10.47.7 31.07.7 37.79.3




Hip positive mechanical work HW+ [J] 13.47.7 23.910.4 11.77.3 12.08.0 27.515.2 9.97.6
Hip negative mechanical work HW [J] 5.32.7 9.04.5 5.44.2 2.73.1 18.572.2 4.65.2
Knee positive mechanical work KW+ [J] 5.15.1 7.06.3 4.86.0 3.44.4 37.419.4 12.422.9
Knee negative mechanical work KW- [J] 11.34.7 17.27.8 7.84.2 6.75.0 6.44.2 52.929.6
Ankle power positive peak APwrPK [W] 129.547.5 152.470.4 72.830.6 38.729.1 136.651.8 65.065.0
Ankle positive mechanical work AW+ [J] 13.14.2 15.26.0 13.16.0 4.33.3 21.18.3 13.38.6
Ankle negative mechanical work AW [J] 7.95.4 7.76.6 11.96.7 5.33.3 5.93.7 25.313.2
First peak of vertical GRF GRFvMax1 [N] 587.2156.1 690.2207.0 618.0163.9 550.6169.1 558.9158.5 833.6281.3
Second peak of vertical GRF GRFvMax2 [N] 600.6147.3 662.1162.4 567.7138.7 558.4155.2 613.6157.4 505.7164.6
Minimum between vertical GRF peaks GRFvMin [N] 401.2115.3 260.186.5 399.1137.1 453.1116.8 377.886.3 390.8114.2
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reliability of gait analysis data include absolute measures of





where SD is the standard deviation of the parameter values from all
subjects [19].
Finally, the correlation of movement analysis’ parameters with
clinical scales (CMTES: Charcot–Marie–Tooth Examination Scores
[22], ONLS: Overall Neuropathy Limitations Scale [23], Walk-12
[24])was assessed by Spearman’s rank correlation coefﬁcient (r).r
values greater than 0.75 indicated good correlation and those
between 0.5 and 0.75 moderate correlation. The level of statistical
signiﬁcance was set at 0.05.
3. Results
Fig. 1 shows, for the whole group of CMT patients, the mean
(SD) proﬁles of the main kinematic and kinetic variables for the NW
task. In Table 1 mean and SD values of all parameters are reported.
Since this study focused on the reliability analysis of curves/
parameters and not on their pattern/values, the discussion on the
latter will be addressed in a forthcoming study.
No subject reported pain during any test that could have
interferedwith the locomotor tasks and affected the results. Table 2reports CMC values of all variables for all tasks. As regards NW, all
kinematic curves showed good reliability, excluding pelvic tilt and
trunk angleswhichhadmoderate reliability. Jointmoments, powers
and GRFs presented good reliability. All EMG curves showed
moderate reliability, excluding peroneus longus and rectus femoris
in FW which showed, respectively, good and poor reliability.
Concerning the other locomotor tasks, CMCs were in general
smaller than in NW, with the exception of trunk ﬂexion and pelvic
tilt for SA. However, most curves showed the same level of
reliability (moderate or good) presented in NW. In particular,
focusing on the sagittal plane, only hallux extension in HW and SA,
knee moment in TW and HW, and all joint power in HW showed
moderate reliability instead of the good reliability presented in
NW. The majority of curves (86%) did not show signiﬁcant
correlation with age, while a moderate level of correlation
(Pearson’s Rho > 0.5; maximal value = 0.68) has been found only
for 23 out of 186 curves, across all tasks. To determine the effective
relevance of this ﬁnding, we split the whole group into two
subgroups of 10 young (<18 years) and 10 adult (18 years)
patients for comparison: only 6 curves showed signiﬁcantly
different CMCs between groups (p < 0.05, U-test). In particular,
adult subgroup presented better reliability than young for ankle
and hip power (HW), pelvis rotation (SA) and pelvic tilt (NW) –
good vs. moderate CMCs – and for trunk rotation (SA and SD) –
moderate vs. poor CMCs.
Table 3 reports ICC and SEM values of the parameters for all
tasks. The global framework showed good or moderate reliability
Fig. 1. Time course of kinematic and kinetic variables selected for CMC analysis for the group of 20 CMT patients (average, solid black lines;SD, shaded area). Arrows indicate
the parameters selected for ICC and SEM analysis. Vertical lines represent, respectively, contralateral foot off, contralateral foot strike and ipsilateral foot off (average, solid lines;
SD, dotted lines). Only task NW is represented.
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Table 2
Test–retest reliability for each locomotor task: CMC values (average over all subjects) of the present study, compared to results from Kadaba et al. [18] (healthy adults) and
McGinley et al. [21] (average values of several studies including CP and stroke subjects). CMCs from Kadaba are the mean of right and left limb CMCs, which the author
reported distinct. Codes for tasks as in Table 1 Code for reliability level: bold type=good (CMC0.75); plain type=moderate (0.5CMC<0.75); shaded type=poor
(CMC<0.5).
Curve CMC
NW FW TW HW SA SD Kadaba et al. 1989 NW McGinley et al. 2009 NW
Angular displacement
Trunk ﬂexion 0.65 0.61 0.68 0.59 0.71 0.64 – –
Trunk bending 0.71 0.55 0.61 0.63 0.59 0.55 – –
Trunk rotation 0.64 0.63 0.62 0.64 0.51 0.60 – –
Pelvic tilt 0.72 0.58 0.64 0.55 0.80 0.72 0.65 0.56
Pelvic obliquity 0.93 0.85 0.89 0.82 0.94 0.90 0.94 0.85
Pelvic rotation 0.94 0.90 0.93 0.84 0.78 0.75 0.83 0.72
Hip ﬂexion 0.99 0.97 0.97 0.94 0.98 0.94 0.99 0.96
Hip adduction 0.93 0.87 0.81 0.80 0.86 0.81 0.95 0.89
Hip rotation 0.85 0.76 0.77 0.73 0.78 0.78 0.83 0.62
Knee ﬂexion 0.99 0.94 0.94 0.91 0.95 0.97 0.99 0.96
Ankle ﬂexion 0.96 0.91 0.91 0.86 0.92 0.92 0.97 0.93
Foot ﬂexion 0.99 0.95 0.96 0.93 0.95 0.96 – –
Foot progression 0.81 0.76 0.76 0.75 0.66 0.75 0.85 0.55
Hallux extension 0.93 0.88 0.86 0.74 0.71 0.86 – –
Joint moment
Hip 0.96 0.92 0.91 0.89 0.92 0.85 0.97 –
Knee 0.89 0.82 0.74 0.70 0.91 0.84 0.94 –
Ankle 0.97 0.92 0.94 0.87 0.90 0.89 0.98 –
Joint power
Hip 0.93 0.77 0.83 0.74 0.90 0.65 – –
Knee 0.88 0.72 0.76 0.61 0.87 0.84 – –
Ankle 0.91 0.77 0.83 0.69 0.72 0.84 – –
GRF
Antero-posterior 0.95 0.97 0.79 0.71 0.80 0.89 0.99 –
Medio-lateral 0.93 0.97 0.94 0.97 0.97 0.91 0.94 –
Vertical 0.86 0.87 0.63 0.78 0.56 0.75 0.99 –
EMG
Tibialis Anterior 0.71 0.72 0.61 0.65 0.62 0.57 0.84 –
Gastroc. Medialis 0.70 0.66 0.66 0.58 0.66 0.56 0.89 –
Soleus 0.74 0.68 0.67 0.57 0.64 0.54 – –
Peroneus Longus 0.70 0.80 0.74 0.55 0.62 0.56 – –
Rectus Femoris 0.64 0.45 0.57 0.53 0.63 0.58 0.84 –
Vastus Medialis 0.67 0.61 0.60 0.54 0.72 0.62 0.86 –
Biceps Femoris 0.64 0.65 0.67 0.60 0.61 0.55 0.82 –
Gluteus Maximus 0.68 0.61 0.63 0.60 0.72 0.52 0.84 –
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other hand, trunk kinematics, especially in sagittal and transverse
planes, were critical for all tasks except SD. Few kinetic parameters
showed poor reliability and only for speciﬁc tasks (KW+ for HW
and SD; HW for SA; APwrPK and AW+ for SD). THS, which was
calculated across the additional tasks TW and HW, had very high
reliability (ICC = 0.95). Comparing ICCs and SEMs of additional
tasks to NW, reliability appeared unchanged or lower, with a few
exceptions, for all tasks similarly.
The results of correlation analysis are summarised in Table 4
(see caption for details). The tasks which presented the larger
number of parameters with a correlation, at least moderate, with
clinical scores were HW (number of parameters: 34), TW (25) and
SA (26).
4. Discussion
Reliable and valid measures are particularly important in the
assessment of patients with CMT, since such disease has slow
progression and variable clinical expression. Nevertheless, only
few impairment and disability outcome measures, including
CMTNS/CMTES, ONLS and 10-m timed walking (T10MW), have
been tested and shown to present substantial to excellent
reliability [22,25].
Gait analysis is a powerful tool to quantitatively characterise
the locomotor functions of patients with gait disturbances,including those presented by CMT patients [7]. However, the
reliability of such data should be known to distinguish real changes
in patient’s condition from non-signiﬁcant variability.
In the present study we assessed, in 20 CMT subjects, the test–
retest reliability of variables and parameters extracted from a
multitask gait analysis protocol. To our knowledge, this is the ﬁrst
study on reliability of gait analysis in CMT patients.
As a general picture, test–retest reliability of all curves (see
Table 2) and parameters (see ICC values in Table 3) was good for
natural walking (NW)with the exception of trunk curves, pelvic tilt
and EMG proﬁles, which showed moderate reliability and trunk
ROM in sagittal and transverse plane, which presented a poor
reliability. Although moderate correlation between CMC and age
was found for a few curves, the global picture does not substantiate
relevant inﬂuence of age on curve reliability.
Comparing NW CMCs to those reported from Kadaba et al. [18]
(relative to normal adults, natural speed), little difference was
observed: arbitrarily considering noticeable a difference in CMC
greater than 0.05, in present study pelvic tilt and rotation had
higher CMCs, while vertical GRF lower CMC; all EMG curves
presented lower CMCs. Comparing NW to McGinley et al. [21]
(median of CMCs from 9 published studies on populations
heterogeneous in age and pathology, including CP children and
adults with stroke), present study CMCs were higher for pelvic
obliquity, tilt and rotation, hip rotation and foot progression, not
signiﬁcantly different for the other variables. It can be concluded
Table 3
Test–retest reliability for each locomotor task: ICC (model 2,k) and SEM values (in absolute units, as in Table 1) of the present study. Codes for tasks as in Table 1 Code for
reliability level: bold type=good (ICC0.75); plain type=moderate (0.5 ICC<0.75); shaded type=poor (ICC<0.5). Units of SEM values are the same as in Table 1.
Parameter Code ICC-SEM
NW FW TW HW SA SD
Spatio-temporal
Gait speed normalized to body height SN 0.95–3.67 0.78–10.12 0.89–7.98 0.85–6.96 0.74–2.69 0.82–2.39
Cadence Cadence 0.91–1.99 0.71–5.77 0.95–3.02 0.91–4.79 0.60–3.21 0.75–3.70
Stride length normalized to body height SLN 0.96–2.16 0.78–6.09 0.87–7.15 0.87–6.33 0.90–1.13 0.68–4.42
Stance duration as percent of gait cycle Stance% 0.92–1.00 0.59–3.34 0.84–2.65 0.86–3.21 0.63–2.37 0.61–3.08
First double support duration as % of gait cycle Double% 0.93–1.11 0.72–2.19 0.97–1.64 0.84–3.62 0.73–2.43 0.82–2.92
Kinematics
Trunk ROM in sagittal plane (ﬂexion) TSROM 0.22–2.41 0.27–5.02 0.20–2.71 0.56–2.18 0.43–5.70 0.71–4.31
Trunk ROM in frontal plane (bending) TFROM 0.77–1.35 0.04–4.07 0.53–2.69 0.37–3.43 0.63–4.84 0.83–5.70
Trunk ROM in transverse plane (rotation) TTROM 0.34–3.96 0.49–5.11 0.17–9.36 0.17–8.40 0.45–5.72 0.95–2.35
Hip angle at foot strike HSHS 0.82–4.26 0.82–4.79 0.80–4.62 0.75–6.29 0.87–3.91 0.85–4.38
Hip angle at foot off HSTO 0.92–4.43 0.91–4.99 0.88–5.81 0.82–7.22 0.84–5.34 0.89–5.90
Hip extension peak HSPK 0.84–4.27 0.82–4.74 0.81–4.62 0.80–5.92 0.90–3.67 0.91–5.24
Hip ﬂex/extension ROM HSROM 0.97–1.55 0.84–4.56 0.83–3.63 0.91–3.07 0.93–2.44 0.96–2.55
Hip ab/adduction ROM HFROM 0.92–1.46 0.83–2.54 0.83–2.31 0.81–2.33 0.80–3.56 0.90–2.33
Knee angle at foot strike KSHS 0.87–3.71 0.89–3.42 0.93–3.49 0.89–3.14 0.90–3.32 0.87–2.85
Knee angle at foot off KSTO 0.93–3.03 0.90–4.03 0.95–3.44 0.96–4.40 0.90–2.74 0.66–4.50
Knee ﬂex/extension ROM KSROM 0.95–2.09 0.63–5.23 0.84–4.90 0.97–4.51 0.87–4.13 0.93–3.19
Knee ﬂexion peak in stance KSPK1 0.93–3.03 0.90–4.03 0.95–3.52 0.96–4.40 0.93–2.71 0.66–4.50
Knee ﬂexion peak in swing KSPK2 0.92–2.75 0.83–4.44 0.89–5.40 0.96–5.22 0.86–3.12 0.90–3.39
Ankle angle at foot strike ASHS 0.81–4.33 0.85–4.55 0.79–5.15 0.92–3.72 0.85–5.02 0.74–5.04
Ankle angle at foot off ASTO 0.78–4.88 0.73–6.03 0.90–4.07 0.84–6.15 0.73–5.74 0.85–5.23
Ankle dorsi/plantaﬂexion ROM ASROM 0.98–2.17 0.98–2.51 0.92–3.87 0.98–2.49 0.91–3.83 0.88–4.21
Ankle dorsi/plataﬂexion ROM in swing ASROMsw 0.87–2.74 0.80–3.91 0.93–2.54 0.92–2.63 0.88–3.23 0.86–4.09
Foot angle at foot strike FoSHS 0.87–4.32 0.90–4.15 0.73–4.44 0.85–4.46 0.56–6.76 0.79–4.79
Mean ankle angle TWmean ankle angle HW THS 0.95–2.72
Kinetics
Hip positive mechanical work HW+ 0.93–2.29 0.74–8.07 0.94–2.34 0.92–2.00 0.98–2.74 0.96–1.45
Hip negative mechanical work HW 0.92–1.08 0.89–1.58 0.93–1.44 0.70–1.56 0.34–10.68 0.93–2.19
Knee positive mechanical work KW+ 0.97–1.11 0.83–2.94 0.73–3.37 0.37–4.85 0.93–4.99 0.06–36.36
Knee negative mechanical work KW 0.86–2.43 0.84–3.15 0.94–1.12 0.85–2.15 0.94–1.40 0.77–14.03
Ankle power positive peak APwrPK 0.92–15.75 0.92–21.25 0.67–26.55 0.70–25.44 0.87–21.25 0.41–137.59
Ankle positive mechanical work AW+ 0.93–1.40 0.95–1.62 0.74–4.25 0.79–2.29 0.94–2.47 0.39–25.17
Ankle negative mechanical work AW 0.95–1.61 0.96–1.74 0.69–5.67 0.82–2.09 0.92–1.62 0.83–7.59
First peak of vertical GRF FvMax1 0.98–24.05 0.97–47.05 0.88–73.06 0.95–42.65 0.95–44.10 0.97–81.09
Second peak of vertical GRF FvMax2 0.96–40.78 0.94–53.47 0.85–75.07 0.95–43.53 0.89–76.21 0.99–24.40
Minimum between vertical GRF peaks FvMin 0.98–22.36 0.81–61.35 0.94–41.05 0.96–33.70 0.97–21.62 0.99–20.13
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and kinetic walking pattern at natural velocity than healthy
subjects or patients with diseases of CNS. Concerning EMG proﬁles,
the lower reliability found in our CMT patients when compared to
literature data on healthy subjects, might be explained by the
presence of muscle denervation and/or the adoption of variable
muscular activation patterns to compensate for distal muscular
weakness.
Additional locomotor tasks showed, in general, a slight
reduction of reliability of curves and parameters. This can be
explained considering the increase of intra-subject variability
associated to a more challenging task than natural walking.
However, in most cases, the level of reliability (moderate-to-
good) shown in NW was not worsened, with the exception of
knee positive work in HW and SD, hip negative work in SA and
ankle positive work and power peak in SD, which are therefore
not suitable for longitudinal studies. The analysis of SEM values
(Table 3), indicating the absolute measure of measurement error
in a test–retest paradigm, conﬁrms this overall picture, with a
general slight increase of SEM values associated to additional
locomotor tasks compared to NW. As expected, parameters with
smaller ICC showed higher SEM values, conﬁrming their poor
level of reliability. In particular, as regard angular parameters,
most of them presented a SEM smaller than 58, the value
indicated by McGinley et al. [21] as error’s threshold for clinical
misinterpretation.
CMT patients typically present a distal-to-proximal progres-
sion of motor and sensory dysfunction. Therefore, depending onthe stage of the pathology, a given locomotor test might be the
most indicated in terms of sensitivity: heel and toe walking at
initial stages, when only distal muscles are involved, step
ascending and descending, at a more advanced stage, when also
proximal muscles might be affected. In particular, THS, i.e. the
difference between the mean ankle ﬂexion/extension angle
measured during toe walking and that measured during heel
walking, showed an optimal reliability (ICC = 0.95, SEM = 2.78), a
signiﬁcant correlation with CMT clinical scores, and, most likely,
high sensitivity to distal motor deﬁciency, since it depends on
ankle muscles recruitment capability. We therefore propose THS
as an outcome measure for evaluation of early stage CMT
patients.
Positive mechanical work at all lower limb joints in SA was
greater than in all other tasks, while negative mechanical work at
knee and ankle was greatest in SD. This reﬂects the biomechanics
of step ascending and descending, which is characterised by a
production and absorption of mechanical work needed, respec-
tively, to raise and to lower the body mass [26]. Interestingly, the
reliability associated to those parameters (HW+, KW+, AW+ in SA
and KW, AW in SD) was always good, indicating that they can
be adopted as outcome measures of concentric and eccentric
muscular contraction capability of lower limb muscles in CMT
patients.
Toe walking, heel walking and step ascending tasks maximised
the number of parameters showing a moderate-to-good correla-
tion with the clinical status of CMT patients (as measured by
CMTES, ONLS and Walk-12). This suggests that in CMT, the
Table 4
Correlation between parameters and clinical scores (Spearman’s rank coefﬁcient—r). Only signiﬁcant correlations (p<0.05) with a correlation coefﬁcient>0.5 are reported.
Codes for tasks as in Table 1 Codes for scores: C=CMTES;W=Walk12; O=ONLS. A r value between 0.5 and 0.75 is marked ‘‘+’’ or ‘‘’’ according to the sign; a r value between
0.75 and 1 is marked ‘‘++’’ or ‘‘’’. Last column and row report the number of signiﬁcant correlations observed, respectively, in each row and column (r values higher than
0.75 are counted twice).
Parameter Code NW FW TW HW SA SD S by row
Spatio-temporal
Gait speed normalized to body height SN W+ 1
Cadence Cadence W+ 1
Stride length normalized to body height SLN O 1
Stance duration as percent of gait cycle Stance% C+ O+ C+ W+ 4
First double support duration as % of gait cycle Double% C+ W+ O+ 3
Kinematics
Trunk ROM in sagittal plane (ﬂexion) TSROM W++ 2
Trunk ROM in frontal plane (bending) TFROM W+ W+ 2
Trunk ROM in transverse plane (rotation) TTROM W+ W+ 2
Hip angle at foot strike HSFS W+ C+ 2
Hip angle at foot off HSFO C+ O+ C+ O+ W+ 5
Hip extension peak HSPK W+ 1
Hip ﬂex/extension ROM HSROM C+ O+ C+ C+ 4
Hip ab/adduction ROM HFROM C+ O+ C+ O+ C+ W+ 6
Knee angle at foot strike KSFS W+ 1
Knee angle at foot off KSFO C+ O+ C+ 3
Knee ﬂex/extension ROM KSROM C+ 1
Knee ﬂexion peak in stance KSPK1 C+ W+ O+ C+ 4
Knee ﬂexion peak in swing KSPK2 C+ 1
Ankle angle at foot strike ASFS W O C W O C O W 9
Ankle angle at foot off ASFO O W 2
Ankle dorsi/plantaﬂexion ROM ASROM C+ C+ W+ 3
Ankle dorsi/plataﬂexion ROM in swing ASROMsw C O W C O W 6
Foot angle at foot strike FoSFS O C O W 4
Mean ankle angle TWmean ankle angle HW THS C+ O+ W+ 3
Kinetics
Hip positive mechanical work HW+ C+ O+ O+ C+ O+ C+ O+ O+ W+ 9
Hip negative mechanical work HW W 1
Knee positive mechanical work KW+ W+ C+ W+ 3
Knee negative mechanical work KW C O C W O 5
Ankle power positive peak APwrPK C O 2
Ankle positive mechanical work AW+ C O W 3
Ankle negative mechanical work AW O W C O O O+ W+ 7
First peak of vertical GRF GRFvMax1 O+ O+ O+ C+ W+ O+ 6
Second peak of vertical GRF GRFvMax2 O+ O+ W+ O+ C+ O+ C+ W+ O+ 9
Minimum between vertical GRF peaks GRFvMin C+ O+ O+ 3
S by column 11 8 25 34 26 15 119
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challenging tasks than on natural walking.
To conclude, instrumented analysis of gait and additional
challenging locomotor tasks is a good candidate to provide reliable
and sensitive outcome measures for CMT patients. An in-depth
analysis of the tables provided in the present work, would help the
reader to choose the task and the parameters of interest based on
their reliability, associated measurement error and level of
correlation with clinical scores.
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